Phreesia (PHR) Earnings Analysis
Phreesia (PHR) next reports earnings on 2026-09-03, consensus EPS 0.11 USD. Last quarter (2026-05-27) it beat with EPS 0.05 USD vs 0.02 USD est (+150%). It has beaten estimates in 8/8 recent quarters (100%). Trailing P/E 65.77.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does PHR next report earnings?
| Next earnings date | 2026-09-03 |
|---|---|
| Consensus EPS estimate | 0.11 USD |
| Revenue estimate | 0.13B |
PHR earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-27 | 0.05 USD | 0.02 USD | +150% | Beat |
| 2026-03-30 | 0.12 USD | 0.06571 USD | +82.6% | Beat |
| 2025-12-08 | 0.1 USD | -0.00036 USD | +27877.8% | Beat |
| 2025-09-04 | 0.01 USD | -0.07 USD | +114.3% | Beat |
| 2025-05-28 | -0.07 USD | -0.13 USD | +46.2% | Beat |
| 2025-03-12 | -0.11 USD | -0.19 USD | +42.1% | Beat |
| 2024-12-09 | -0.25 USD | -0.27 USD | +7.4% | Beat |
| 2024-09-04 | -0.31 USD | -0.37 USD | +16.2% | Beat |
Beat rate: 8/8 (100%) over reported quarters with consensus data.
PHR valuation and analyst view
| Trailing P/E | 65.77 |
|---|---|
| Trailing EPS | 0.15068 USD |
| Price / book | 1.70 |
| Dividend yield | 0.00% |
| Market cap | 0.62B |
| Analyst consensus | Buy (18 buy / 7 hold / 0 sell) |
| Avg price target | 12.17 USD |
Related research pages
Frequently asked questions
When is Phreesia (PHR)'s next earnings date?
Phreesia is next scheduled to report on 2026-09-03, with a consensus EPS estimate of 0.11 USD and revenue estimate of 0.13B.
Did PHR beat earnings last quarter?
In its 2026-05-27 report, PHR posted EPS of 0.05 USD versus a 0.02 USD estimate — a beat of 150%.
What is PHR's earnings track record?
Over the last 8 reported quarters with consensus data, PHR beat estimates 8 times (100%).
What is PHR's current P/E ratio and EPS?
PHR trades at a trailing P/E of 65.77 on trailing EPS of 0.15067693372259383 USD.
What do analysts rate PHR?
Analyst consensus is "Buy" across 25 ratings (0 strong buy, 18 buy, 7 hold, 0 sell, 0 strong sell). Average 12-month price target: 12.17 USD.